The agency flagged several violations at a compounding pharmacy owned by Hims & Hers, including “infestation by rodents, ...

Novo Nordisk’s CEO says compounded GLP-1 knockoffs sourced from overseas ingredients could endanger patients and undermine ...

A Houston-based compounding pharmacy that was recently roped into Eli Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in less than a year. The FDA has ...

Hims said it “deciding to stop offering access” to the treatment following escalating legal threats — among them a patent infringement suit Novo Nordisk filed against the company on Monday.

Wesley Pharmaceuticals, a state-of-the-art 503B outsourcing facility, and sister brand of the nation’s leading 503A and 503B compounding pharmacy, Olympia Pharmaceuticals, today announced the launch ...

Compounding pharmacies can offer a life-saving medicine to patients who may not be able to take standard medication, but the industry is in the midst of challenges because of rules and regulations ...

ORANGE, Calif., Aug. 28, 2025 /PRNewswire/ -- Has a new breed of "Pharma Bros" emerged to undermine legitimate providers and potentially put patient safety at risk? They're not hedge fund traders or ...